MétaCan
Menu
← Back to cohort
Record W4388124364 · doi:10.1101/2023.10.31.23297859

Cardiovascular risk prediction using metabolomic biomarkers and polygenic risk scores: A cohort study and modelling analyses

2023· preprint· en· W4388124364 on OpenAlexfundno aff
Scott C. Ritchie, Xilin Jiang, Lisa Pennells, Yu Xu, C. Coffey, Yang Liu, Joel T. Gibson, Praveen Surendran, Savita Karthikeyan, Samuel A. Lambert, John Danesh, Adam S. Butterworth, Angela Wood, Stephen Kaptoge, Emanuele Di Angelantonio, Michael Inouye

Bibliographic record

VenuemedRxiv · 2023
Typepreprint
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMetabolomics and Mass Spectrometry Studies
Canadian institutionsnot available
FundersEconomic and Social Research CouncilMedical Research CouncilEngineering and Physical Sciences Research CouncilCanadian Institutes of Health ResearchNational Institute for Health and Care ResearchScience and Technology Facilities CouncilDell EMCDepartment of Health and Social CareNIHR Cambridge Biomedical Research CentreBritish Heart FoundationWellcome Trust
KeywordsPolygenic risk scoreMetabolomicsCohortMedicineInternal medicineComputational biologyBioinformaticsBiologyGeneticsGenotypeSingle-nucleotide polymorphismGene

Abstract

fetched live from OpenAlex

Abstract Background and Aims Metabolomic biomarker scores and polygenic risk scores (PRS) have shown promise for improving cardiovascular disease (CVD) prediction, but have not yet been evaluated in the context of current prediction models (SCORE2) and ESC recommendations for 10-year prediction of fatal and non-fatal CVD. Methods Metabolomics biomarker scores were constructed and compared to PRS and SCORE2 in 297,463 UK Biobank participants (8,919 incident CVD cases) aged 40–69 without previous CVD, diabetes, or lipid-lowering treatment. Improvement in risk discrimination when added to SCORE2 was assessed using Harrel’s C-index. Improvement in risk stratification following ESC guideline risk thresholds was assessed using categorical net reclassification. Population modelling was subsequently applied to estimate the impact on CVD prevention if applied at scale. Results Risk discrimination provided by SCORE2 (C-index: 0.719) was similarly improved by addition of metabolomic biomarker scores (ΔC-index: 0.010 [0.009–0.012]) and PRSs (ΔC-index 0.009; [0.008–0.011]). Addition of both metabolomic biomarker scores and PRSs to SCORE2 yielded the largest improvement risk discrimination, with ΔC-index 0.018 (0.016–0.020). Concomitant improvements in risk stratification were observed in categorical net reclassification index, with net case reclassification of 11.99% (10.98–12.99%). Modelling metabolic biomarker scores and PRSs for targeted risk-reclassification increased the number of CVD events prevented per 100,000 screened from 209 to 368 (ΔCVD prevented : 160 [151–169]) while essentially maintaining the number of statins prescribed per CVD event prevented. Conclusions Combining NMR scores and PRSs with SCORE2 enhanced prediction of first-onset CVD and could have substantial population health benefit if applied at scale.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.014
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.074

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0140.011
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.004
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.053
GPT teacher head0.300
Teacher spread0.247 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2023
Admission routes1
Has abstractyes

Explore more

Same venuemedRxiv→Same topicMetabolomics and Mass Spectrometry Studies→French-language works237,207→